141 related articles for article (PubMed ID: 23574711)
1. Vincristine could partly suppress stromal support to T-ALL blasts during pegylated arginase I treatment.
Kwong-Lam F; Chi-Fung CG
Exp Hematol Oncol; 2013 Apr; 2(1):11. PubMed ID: 23574711
[TBL] [Abstract][Full Text] [Related]
2. The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated-recombinant arginase I BCT-100.
De Santo C; Booth S; Vardon A; Cousins A; Tubb V; Perry T; Noyvert B; Beggs A; Ng M; Halsey C; Kearns P; Cheng P; Mussai F
Int J Cancer; 2018 Apr; 142(7):1490-1502. PubMed ID: 29168171
[TBL] [Abstract][Full Text] [Related]
3. Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines.
Avramis IA; Kwock R; Avramis VI
Anticancer Res; 2001; 21(4A):2281-6. PubMed ID: 11724283
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human arginase induces apoptosis through oxidative stress and cell cycle arrest in small cell lung cancer.
Xu S; Lam SK; Cheng PN; Ho JC
Cancer Sci; 2018 Nov; 109(11):3471-3482. PubMed ID: 30155941
[TBL] [Abstract][Full Text] [Related]
5. Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts.
Lam SK; Li YY; Xu S; Leung LL; U KP; Zheng YF; Cheng PN; Ho JC
Respir Res; 2017 May; 18(1):80. PubMed ID: 28464918
[TBL] [Abstract][Full Text] [Related]
6. Vincristine but not imatinib could suppress mesenchymal niche's support to lymphoid leukemic cells.
Fung KL; Liang RH; Chan GC
Leuk Lymphoma; 2010 Mar; 51(3):515-22. PubMed ID: 19925050
[TBL] [Abstract][Full Text] [Related]
7. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion.
Cheng PN; Lam TL; Lam WM; Tsui SM; Cheng AW; Lo WH; Leung YC
Cancer Res; 2007 Jan; 67(1):309-17. PubMed ID: 17210712
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folate.
Miyachi H; Takemura Y; Kobayashi H; Ando Y
Jpn J Cancer Res; 1997 Sep; 88(9):900-6. PubMed ID: 9369939
[TBL] [Abstract][Full Text] [Related]
9. The synergism of 6-mercaptopurine plus cytosine arabinoside followed by PEG-asparaginase in human leukemia cell lines (CCRF/CEM/0 and (CCRF/CEM/ara-C/7A) is due to increased cellular apoptosis.
Nandy P; Periclou AP; Avramis VI
Anticancer Res; 1998; 18(2A):727-37. PubMed ID: 9615712
[TBL] [Abstract][Full Text] [Related]
10. Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma.
Lam SK; Yan S; Xu S; U KP; Cheng PN; Ho JC
Oncogenesis; 2019 Feb; 8(3):18. PubMed ID: 30808864
[TBL] [Abstract][Full Text] [Related]
11. [Statins Regulate the Proliferation and Apoptosis of T-ALL Cells through the Inhibition of Akt Pathway].
Wang JJ; Tian Y; Xu KL; Fu RX; Niu MS; Zhao K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):359-367. PubMed ID: 29665899
[TBL] [Abstract][Full Text] [Related]
12. Resistance to apoptotic cell death in a drug resistant T cell leukaemia cell line.
Geyp M; Ireland CM; Pittman SM
Leukemia; 1996 Mar; 10(3):447-55. PubMed ID: 8642860
[TBL] [Abstract][Full Text] [Related]
13. Comparison of DiOC(6)(3) uptake and annexin V labeling for quantification of apoptosis in leukemia cells and non-malignant T lymphocytes from children.
Ozgen U; Savaşan S; Buck S; Ravindranath Y
Cytometry; 2000 Feb; 42(1):74-8. PubMed ID: 10679746
[TBL] [Abstract][Full Text] [Related]
14. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest.
Lam TL; Wong GK; Chong HC; Cheng PN; Choi SC; Chow TL; Kwok SY; Poon RT; Wheatley DN; Lo WH; Leung YC
Cancer Lett; 2009 May; 277(1):91-100. PubMed ID: 19138817
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of heme oxygenase-1 in microenvironment mediates vincristine resistance of B-cell acute lymphoblastic leukemia by promoting vascular endothelial growth factor secretion.
Yu K; Wang J; Lu T; Ma D; Wei D; Guo Y; Cheng B; Wang W; Fang Q
J Cell Biochem; 2019 Oct; 120(10):17791-17810. PubMed ID: 31264739
[TBL] [Abstract][Full Text] [Related]
17. CDH1 and IL1-beta expression dictates FAK and MAPKK-dependent cross-talk between cancer cells and human mesenchymal stem cells.
Al-toub M; Vishnubalaji R; Hamam R; Kassem M; Aldahmash A; Alajez NM
Stem Cell Res Ther; 2015 Jul; 6(1):135. PubMed ID: 26204886
[TBL] [Abstract][Full Text] [Related]
18. [Reversing effect of brassinolide on multidrug resistance of-CCRF-VCR1000 cells and a preliminary investigation on its mechanisms].
Xian LJ; Li YQ; Liu RY; Cao QY; Sun J
Yao Xue Xue Bao; 2005 Feb; 40(2):117-21. PubMed ID: 15875665
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
Nuessler V; Stötzer O; Gullis E; Pelka-Fleischer R; Pogrebniak A; Gieseler F; Wilmanns W
Leukemia; 1999 Nov; 13(11):1864-72. PubMed ID: 10557064
[TBL] [Abstract][Full Text] [Related]
20. Vincristine induces procoagulant activity of the human lymphoblastic leukemia cell line Jurkat through the release of extracellular vesicles.
Pluchart C; Poitevin G; Colinart-Thomas M; Guimard G; Audonnet S; Terryn C; Nguyen P
J Thromb Thrombolysis; 2019 Aug; 48(2):195-202. PubMed ID: 31175530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
